イチキ ヨシノブ
ICHIKI Yoshinobu
市来 嘉伸 所属 埼玉医科大学 医学部 国際医療センター 呼吸器外科 職種 専任講師 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report. |
掲載誌名 | 正式名:Annals of translational medicine |
巻・号・頁 | 7(20),590-590頁 |
著者・共著者 | Huali Hu,Shuai Zou,Ruofu Xu,Yoshinobu Ichiki,Dirk De Ruysscher,Fenglei Yu,Aihui Liao |
発行年月 | 2019/10 |
概要 | Patients with N3 non-small cell lung cancer (NSCLC) have unresectable tumors. Although significant progress has been made in the past decades for such tumors, the average median survival time remains at 10 months. Equally dismal long-term survival rates were reported with the average 5-year-suvival rate at 9%. Here, we report on a case of a patient with locally advanced disease that was treated with conversion therapy using targeted anti-PD-1 immunotherapy with platinum-based chemotherapy. Following this therapeutic regimen, the tumor showed a reversion to pN0 from pN3 and the patient showed a progression free survival time of at least 33 months. |
DOI | 10.21037/atm.2019.09.113 |
PMID | 31807571 |